P. Boydell

Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review

Use of bacteriophages in the treatment ofPseudomonas aeruginosainfections

Syndemics and the biosocial conception of health

A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic‐resistant Pseudomonas aeruginosa; a preliminary report of efficacy

Bacteriophage resistance mechanisms

Pseudomonas Aeruginosa: Resistance to the Max

The Rationale for Using Bacteriophage to Treat and Prevent Periprosthetic Joint Infections

Skeletal infections: microbial pathogenesis, immunity and clinical management

Understanding the mechanisms and drivers of antimicrobial resistance

Phage treatment of human infections

<p>Mechanistic research holds promise for bacterial vaccines and phage therapies for <em>Pseudomonas aeruginosa</em></p>

Bacteriophage therapy — cooked goose or Phoenix rising?

Review of Neospora caninum and neosporosis in animals

Horner's syndrome associated with Neospora infection

Antimicrobial Resistance in ESKAPE Pathogens

Multiplication of therapeutically administered bacteriophages in Pseudomonas aeruginosa infected patients

Idiopathic Horner's syndrome in the golden retriever

Horner's syndrome following intrathoracic tube placement

Horner's syndrome following cervical spinal surgery in the dog